Go to Top

News Releases

6/1/16
Osseon Expands Its Independent Distribution Network


5/30/16
Honoring Our Veterans


4/4/2016
Osseon’s Strong Revenue Growth Continues


3/2/2016
Osseon Reports Strong Growth in 2016


1/28/2016
Osseon Reports 2015 Results


11/18/2015
Osseon Expands Product Line


6/14/2013
Osseon® Therapeutics Announces Another VCF Product 


4/16/2013
Osseon® announces Balloon Osseoplasty Case in Lima, Ohio


1/31/2013
Osseon® Closes $14 Million Equity Financing 


10/24/2012
Osseon® Receives FDA Clearance for Latest Steerable VCF Product


10/15/2012
Osseon® Therapeutics’ New Product Accelerates Growth


9/11/2012
Osseon® Therapeutics releases Osseoflex® SN+ (steerable needle) in the U.S.


8/29/2012
Osseon® Therapeutics Names Ron Clough as New Chief Operating Officer


2/27/2012
Osseon® Announces International Distribution Agreement with Aesculap


2/22/2012
Osseon® Announces CE Mark Approval for New Vertebral Augmentation Device
- the Osseoflex® SB steerable balloon 


09/01/2011
Osseon® Announces Commercial Release of Osseoflex® SN steerable needle


07/26/2011
Osseon® Launches in India


03/28/2011
Osseon® Therapeutics Introduces Osseoflex® BT steerable bone tamp


12/05/2010
Osseon® Therapeutics Names Gary Coughlen, CPA as New Chief Financial Officer


10/05/2010
Osseon® Therapeutics Introduces New Osseoflex® DR steerable bone drill


10/06/2010
Osseon® Therapeutics, Inc. Signs Distribution Agreement with DePuy Spine, Inc.


09/29/2010
Osseon™ Therapeutics Treats 1,000th Patient with Osseoplasty™ Procedure for Vertebral Compression Fractures


09/22/2010
Osseon™ Therapeutics, Inc. Announces New Member to Board of Directors


07/14/2010
Osseon™ Therapeutics Receives Patent Allowance for Novel Spinal VCF Treatment Devices


02/16/2010
Osseon™ Therapeutics Launches the Osseoflex Steerable Needle in Europe


12/01/2009
Osseon™ Therapeutics Announces Osseoflex and Osseoflex DR Systems Receive Canadian Medical Device Licenses for Marketing and Clinical Use in Canada


09/15/2009
Osseon™ Therapeutics Announces CE Mark Approval for Commercial Release in the European Union


09/15/2009
Osseon™ Therapeutics Announces Five-Year Agreement with MBA Incorporado, SL to Distribute Osseon Suite of Products in the European and South American Markets


01/26/2009
Osseon™ Therapeutics Announces the Commercial Release of Osseoflex™ and Osseoperm™